|FDA’s MedWatch Safety Alerts: April 2013
||FDA’s MedWatch Safety Alerts alert consumers to problems with quality or safety of medical products. The April listing includes products such as anti-seizure medications, multivitamin supplements, mattress covers, blood glucose meters and compounded drugs.
|Consumer Update Analytics
||This page contains the most recent Consumer Update data available and links to past Consumer Update Analytics web pages.
|Stay Safe in the Summer Sun
||FDA has taken steps on multiple fronts to protect consumers from the skin damage that can be caused by too much exposure to the sun. This is the first summer in which FDA's new rules governing sunscreen labeling are in effect. And FDA is supporting "DonÃ¢â‚¬â„¢t Fry Day" on May 24.
|FDA's Role in Regulating Safety of GE Foods
||GMOs, genetically modified organisms, biotech foods, or genetically engineered foods - whatever name they're called - seem to be a captivating topic. Learn more about them and how they are regulated in this FDA Consumer Update.
|Pregnancy: A Time for Special Caution
||Pregnant and breastfeeding women can turn to FDA's Office of Women's Health for important health information, including details about the risks and benefits of taking medication during this special time.
|Keep Listeria Out of Your Kitchen
||Keep Listeria at bay by keeping your refrigerator temperature low and carefully cleaning kitchen surfaces.
|Know the Risks of Indoor Tanning
||Exposure to ultraviolet (UV) radiation - whether outdoors from the sun, or indoors under a sunlamp - causes damage to your skin, including skin cancer. Find out how FDA is proposing to change how it regulates sunlamps, including requiring labeling recommending that young people not use these devices.
|FDA to Investigate Added Caffeine
||Deputy Commissioner for Foods and Veterinary Medicine Michael R. Taylor discusses his concerns about the increasing number of caffeinated products and their impact on children.
|Fighting the Impact of Antibiotic-Resistant Bacteria
||David White, chief science officer in FDA's Office of Food and Veterinary Medicine, and Edward Cox, director of FDA's Office of Antimicrobial Products, explain the efforts FDA is making to combat the public health impact of antibiotic-resistant bacteria.
|Clinical Trials Shed Light on Minority Health
||FDA is working to increase minority participation in the clinical trials that test new medical products. Members of minority groups are move vulnerable to certain diseases, but are under-represented in these trials.
Consumer Health Information Updates